CNSY
Cerenome Inc.
CNSY | NASDAQ
$1.70
-$0.04 (-2.30%)
At close: Oct 30, 2026, 4:00 PM ET
$1.71
+$0.01 (+0.46%)
Pre-market:
Nov 2, 2026, 6:51 AM ET
-2.30%
(1D)No price chart data available for 1D timeframe.
Rating
48.5
-1.0 ptsFundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #311/1028 (Top 30%)
Key Statistics
Market Data
Market Cap $12.9M
1D Range
1.66 1.76
52W Range
1.56 3.96
Valuation (TTM)
PE -0.38
PB 2.36
EV/EBITDA -0.19
Valuation (NTM)
Forward PE N/A
Forward PEG 0.00
Price Target $25.00
Cash Flow
FCF Yield -182.5%
SBC Adj. FCF Yield -206.5%
SBC Impact -13.1%
Margins
Gross Margin 89.6%
Operating Margin -628.1%
FCF Margin -560.3%
Growth (CAGR)
Revenue 3Y | 5Y 17.6% |
31.6%
Dil EPS 3Y | 5Y 84.5% |
63.2%
FCF 3Y | 5Y -37.8% |
-15.6%
Returns
ROA -185.9%
ROE -394.2%
ROIC -479.4%
Financial Health
Net Cash
$8.54M
Current Ratio 1.37
Interest Coverage -8.56
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and mark...
Sector Healthcare
Industry Medical - Pharmaceuticals
Employees 28
IPO Date Aug 3, 2026
Website www.plustherapeutics.com
Fiscal Year n/a
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
2
Consensus
Buy
Price Target
$25.00
Upside
+1370.59%
Buy (2)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove CNSY